Dr. Rio SUGIMURA’s Research interest: The mission of The Blood Engineering Lab (BEL) is to define fundamental principles of anti-cancer immune cells and apply these insights toward improving the chimeric antigen receptor (CAR) technology and anti-PD-1 immunotherapy. We apply cutting-edge approaches including single-cell RNA sequencing, molecular barcoding, organoids, and stem cell differentiation. The goal is to invent new tools for understanding and treating cancers.